CD Biosynsis offers advanced Saccharomyces cerevisiae-Based Assay and Modeling Services, integrating cutting-edge experimental analysis with powerful computational modeling to facilitate rational strain design and optimization in this eukaryotic host. Saccharomyces cerevisiae (baker's yeast) is a versatile host known for its complex eukaryotic metabolism, including compartmentalization (organelles) and robust post-translational modification (PTM) machinery, making it ideal for synthesizing complex molecules. Our services move beyond simple genetic modification by providing a deep, quantitative understanding of the host's behavior. We combine high-precision In Vitro and In Vivo assays (metabolomics, fluxomics, protein activity) with Constraint-Based Modeling (CBM) and Kinetic Modeling to accurately predict metabolic flux, optimize gene expression levels, and pinpoint systemic bottlenecks within the yeast system. This integrated approach minimizes trial-and-error experimentation, ensuring rapid and predictable development of high-performance Saccharomyces cerevisiae strains.
Get a QuoteThe highly flexible and compartmentalized metabolic network of Saccharomyces cerevisiae demands sophisticated tools to guide effective metabolic engineering efforts. Our Assay and Modeling platform bridges the gap between genotypic edits and phenotypic outcomes. By experimentally characterizing key cellular metrics (Assays) and using this data to parameterize predictive Models, we can accurately simulate the effects of genetic modifications before they are built in the lab. This is particularly crucial in yeast, where subcellular localization and PTMs significantly influence enzyme function. This integrated approach allows our clients to make informed decisions, prioritize the most effective genetic targets, and drastically reduce the number of iterative experiments required to achieve optimal product yield and purity.
Metabolomics Profiling (Targeted/Untargeted)
Comprehensive GC-MS/LC-MS analysis of intracellular and extracellular metabolites to quantify pathway intermediates and track precursor consumption, accounting for organelle-specific metabolite pools.
Fluxomics (Isotope Tracing)
Measurement of metabolic fluxes via 13C labeling and mass spectrometry to accurately determine carbon flow through central metabolism and target pathways, including fluxes between cytosol and mitochondria.
Proteomics & PTM Analysis
Quantification of protein levels and analysis of post-translational modifications (PTMs) to map enzyme activity and folding status in response to engineering and environmental changes.
Constraint-Based Modeling (CBM/FBA)
Using Flux Balance Analysis (FBA) based on the Saccharomyces cerevisiae genome-scale model to predict maximum theoretical yields, optimize substrate utilization, and propose effective gene knockouts, integrating compartmental analysis.
Metabolic Control Analysis (MCA)
Identifying the rate-limiting steps (bottlenecks) and determining the sensitivity of metabolic fluxes to changes in enzyme activity or concentration, particularly for highly regulated eukaryotic enzymes.
Kinetic Modeling
Development of dynamic models to simulate time-dependent changes in cell growth, substrate uptake, and product formation under various fermentation strategies, including changes in organelle respiration.
Optimal Target Recommendation
Using model outputs (e.g., FBA predictions and MCA results) to recommend the most impactful genetic targets for knockout, knock-in, or expression tuning, focusing on localization and PTM impact.
Predictive Localization
Simulating the effect of adding signal peptides to enzymes to ensure correct targeting to mitochondria or peroxisomes for optimal pathway efficiency in yeast.
Fermentation Condition Simulation
Simulating the strain's performance under different media compositions, oxygen levels, and nutrient feeding strategies to optimize industrial process parameters.
We connect high-quality experimental data with predictive simulation to deliver highly efficient strain optimization.
1. Initial Modeling & Hypothesis
2. Experimental Strain Culturing
3. Quantitative Data Assays
4. Model Validation & Refinement
Establish a compartmentalized computational model (FBA, Kinetic) based on the Saccharomyces cerevisiae native metabolism and target pathway.
Simulate effects of potential edits and predict initial bottlenecks/optimal conditions.
Generate initial hypothesis and experimental plan for target verification.
Cultivate wild-type and initially engineered Saccharomyces cerevisiae strains under tightly controlled fermentation conditions (e.g., chemostat culture).
Collect biomass and supernatant samples at specific time points reflecting key metabolic transitions.
Integrate new experimental assay data to validate and refine the computational model parameters.
Identify prediction errors, extract new design rules specific to Saccharomyces cerevisiae's PTM and compartmental constraints, and recommend the final optimization strategy.
Deliver the predictive model and data-driven optimization strategy.
Compartmental Modeling
Use of a Saccharomyces cerevisiae genome-scale model that accurately tracks fluxes between organelles (e.g., mitochondria and cytosol), essential for energy and cofactor balancing in yeast.
PTM & Localization Focus
Assay platform includes proteomics focused on post-translational modifications and subcellular localization analysis, linking protein function directly to model inputs, a key eukaryotic feature.
High-Resolution Flux Analysis
Expertise in both experimental 13C-Fluxomics and computational FBA/MCA modeling for accurate flux determination and visualization in complex Saccharomyces cerevisiae metabolism.
Data-Driven Rational Design
Computational modeling is performed before and refined after strain testing to ensure all genetic edits are maximally effective and guided by current experimental data.
1. What is the primary benefit of using modeling for Saccharomyces cerevisiae engineering?
Modeling provides a computational prediction of the maximum theoretical yield of a product, allowing engineers to identify limiting factors and prioritize gene edits (knockouts, tuning) before expensive lab work begins.
2. How does the Saccharomyces cerevisiae model handle cellular compartmentalization?
Our model is compartmentalized, meaning it tracks metabolic fluxes and cofactor balances separately for key organelles like the mitochondria and cytosol, accurately reflecting true yeast metabolism.
3. How do you parameterize your computational models?
Model parameters are derived from high-resolution experimental assays, including metabolite concentrations (Metabolomics), enzyme activity levels (Proteomics), and measured metabolic fluxes (Fluxomics/13C labeling).
4. Can the assay service analyze post-translational modifications (PTMs)?
Yes. Our proteomics service includes dedicated analysis of PTMs (e.g., phosphorylation, glycosylation), which is crucial for determining the functional state of enzymes in the Saccharomyces cerevisiae host.
5. What is the benefit of Kinetic Modeling over FBA in yeast?
FBA provides steady-state flux predictions. Kinetic Modeling simulates dynamic processes like substrate feeding and the Pasteur effect, allowing us to optimize complex fermentation strategies over time.
6. Can you analyze the flux of a heterologous (non-native) pathway?
Yes. By integrating the heterologous pathway into the Saccharomyces cerevisiae genome-scale model and confirming flux via 13C-Fluxomics, we can accurately quantify the carbon flow efficiency through the engineered route.
7. How do you ensure samples reflect the true metabolic state?
We use rapid quenching protocols (e.g., methanol/dry ice) immediately upon harvesting the Saccharomyces cerevisiae cells to instantly halt enzymatic activity, ensuring the measured metabolite levels accurately represent the in vivo state.
8. What type of output recommendation do you provide after model refinement?
We provide a prioritized list of actionable genetic targets, including specific promoter strengths, gene repression levels (CRISPRi targets), or instructions for optimal enzyme localization (signal peptides) to achieve the calculated optimal flux balance.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.